SHAANXI FUJIE PHARMACEUTICAL CO.,LTD

Shaanxi Fujie Pharmaceutical Co., Ltd is a Chinese producer specializing in licorice root extracts and related plant-based pharmaceutical ingredients. Established in 1993, the company has developed a comprehensive licorice industry chain that spans licorice import, wild licorice conservation, artificial licorice planting, and production of licorice-derived products. The organization produces a wide range of licorice-based compounds, including glycyrrhizic acid derivatives such as Enoxolone (18β-Glycyrrhetinic Acid), Mono Ammonium Glycyrrhinate (MAG), and Glycyrrhizic acid A, as well as related compounds like Dipotassium Glycyrrhetate and Glabridin. In addition to primary extracts, the portfolio includes licorice flavonoids such as Licochalcone A and Glabridin, along with various licorice extracts in forms including powders, sprays, blocks, and liquids.

Located at YuanQu Yi Road, Qinghe Food Industrial Park, SanYuan County, Shaanxi Province, the company positions itself as a global supplier of licorice root extracts and other plant-based products, aiming to create added value for customers worldwide. Its product line extends across multiple applications and industries, including pharmaceuticals, food, cosmetics, tobacco, and dietary supplements. The company indicates GMP certification in China and notes ongoing registration efforts in the United States to meet FDA standards.

Shaanxi Fujie Pharmaceutical Co., Ltd emphasizes its ability to serve both domestic and international markets, with sales personnel capable of fluent English to facilitate communication with customers. Major markets cited include Japan, Korea, and North America. The profile reflects a focus on quality control, product diversification, and a global-oriented supply strategy within the natural extracts space.